On Tuesday, Shares of Pfizer Inc.(NYSE:PFE), subtract -1.43% and closed at $33.13 in the last trading session. The last trading range of the stock ranges between $32.94 and $33.57. The company’s Market capitalization is $201.25 Billion with the total Outstanding Shares of 6.07 billion. During the 52-week trading session the minimum price at which share price traded, registered at $28.25 and reached to max level of $37.39. Pfizer Inc. (PFE) today announced results from the Phase 3 S-TRAC clinical trial (Sunitinib Trial as Adjuvant Treatment of Renal Cancer) investigating SUTENT® (sunitinib) as adjuvant therapy. The trial showed SUTENT extended disease-free survival (DFS) by more than one year versus placebo in patients who were at high risk for recurrence after surgical resection of renal cell carcinoma (RCC) (HR 0.761; P=0.030 [95% CI: 0.594-0.975]). These results will be presented today during a Presidential Symposium (Abstract #LBA11_PR) at the ESMO 2016 Congress, the annual meeting of the European Society for Medical Oncology being held in Copenhagen, Denmark. The results have also been published online by The New England Journal of Medicine.
Adjuvant therapies are treatments that can be given to reduce the likelihood of the cancer returning after initial treatment such as surgery.
“We are encouraged by the S-TRAC results because this is the first clinical trial to show increased disease-free survival in the adjuvant setting for RCC,” said lead investigator Alain Ravaud, M.D., Ph.D., CHU de Bordeaux Hôpital Saint André. “These data are promising for RCC patients as there are no effective treatments currently available in this setting.”
Honeywell International Inc. (NYSE:HON), dropped -0.96% and closed at $105.78 in the last trading session. The last trading range of the stock ranges between $105.26 and $106.43. During the 52-week trading session the minimum price at which share price traded, registered at $93.71 and reached to max level of $120.02. Honeywell (HON) recently declared it has updated its previous guidance for the third quarter of 2016 to reflect the separation of the former Automation and Control Solutions reporting segment into two new reporting segments; the acquisition of Intelligrated, which closed on August 29, 2016; the sale of the Honeywell Technology Solutions (HTSI) government services business, which closed on September 16, 2016; the spin-off of Resins and Chemicals as AdvanSix Inc., which became effective on October 1, 2016; and lower outlooks in certain business segments.
The company also declared it has elected to adopt the Financial Accounting Standards Board’s (FASB) Accounting Standards Update 2016-09 for stock compensation in the third quarter, which is in advance of the mandatory 2017 effective date. As a result of the early adoption, the company is required to report the impacts as though the accounting standard update had been adopted on January 1, 2016. Accordingly, the first- and second-quarter results have been recast to reflect a $0.03 and $0.04 tax benefit, respectively. Benefits from the accounting change and sale of HTSI will be deployed to fund restructuring and other charges in the third quarter.